Columbia Laboratories Inc. - Product Pipeline Review - 2012


Hyderabad, Andhra Pradesh -- (SBWIRE) -- 07/03/2012 -- ReportReserve’s pharmaceuticals report, “Columbia Laboratories Inc. - Product Pipeline Review - 2012” provides data on the Columbia Laboratories Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Columbia Laboratories Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Columbia Laboratories Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.


- Columbia Laboratories Inc. - Brief Columbia Laboratories Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Columbia Laboratories Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Columbia Laboratories Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Columbia Laboratories Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Columbia Laboratories Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Columbia Laboratories Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Columbia Laboratories Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Columbia Laboratories Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Columbia Laboratories Inc. and identify potential opportunities in those areas.

For further information visit